2 Sources
[1]
UK companies line up to replace Palantir in NHS contract
The government is expected to rule out triggering a break clause but will instead announce a new procurement process Several UK companies are vying to replace Palantir in the NHS after the government signalled it would put a lucrative health data contract up for tender on terms more favourable to
[2]
Britain looks beyond Palantir as it reopens the £330m NHS tender
London is moving to loosen its ties with Palantir by reopening its next contract to rival bidders. Whitehall previously allowed the US tech giant to handle sensitive NHS health data, drawing sharp criticism from lawmakers over entrusting confidential records to a foreign company. The UK government
Share
Copy Link
Britain is reopening the £330m National Health Service data platform contract to competition. British-led bidders are lining up to displace Palantir, and a new 'UK supplier' rule could decide it.
The UK government is expected to put the £330m contract to run the National Health Service's Federated Data Platform out to tender again, rather than exercise a break clause that would cut Palantir loose by March
1
. If the expectation holds, the choice decides how Palantir could lose the contract: through a competition it would have to win rather than an automatic exit1
.Source: Market Screener
Downing Street has said it wants to reduce the country's long-term reliance on Palantir and back a domestic alternative instead
2
. Palantir is the US technology company known for work on American immigration enforcement and with Israeli military intelligence1
2
. The move follows pressure that has built from activists, Labour MPs and healthcare staff1
. Unison, Britain's biggest public sector union, says its members using the platform are unsatisfied with it1
. It also lands days after the government announced, on November 6, an extension of the Palantir agreement2
. Because the government is expected to rule out the break clause, Palantir keeps running the platform until any new process concludes1
.
Source: FT
The tender fits a wider European shift away from Palantir
2
. France's Arcadia intelligence platform, launched in 2025, is being tested and is expected to be fully operational by 20272
. Prime Minister Sébastien Lecornu has announced that the country's domestic intelligence services have replaced Palantir with ChapsVision2
. Germany has narrowed, within a year, a defence shortlist that would cover roughly 80% of its needs, and Helsing unveiled its Clarity military intelligence platform last week2
. Palantir's Louis Mosley said demand in Europe remained strong despite these domestic-alternative efforts2
. The company's Maven Smart System is still widely used by Ukraine, the Pentagon and the military headquarters of the North Atlantic Treaty Organization2
.The most visible organised British alternative announced itself on Monday: the Drystone Health AI Collaboration, a group of more than 20 companies that will bid to run the platform
1
2
. It is led by Shane Tickell, head of health consultancy Temple Black1
. Its members include health service contractors Voror Health Technologies and Black Pear Software, which previously bid for the platform and lost1
. So do the UK arm of Toronto-listed VitalHub and IMS Maxims, a subsidiary of Constellation Software1
."I do not believe [Palantir] provides good value for the NHS," said Tickell
1
. He argues his consortium is larger and better capitalised than earlier British-led attempts1
.Quantexa, a London-based data analytics company, is preparing a fresh bid three years after losing the original award
1
. Its contracts include HM Revenue and Customs and banks such as Standard Chartered; it already does health service work in Cheshire and Merseyside1
. If the government does choose a British firm, Quantexa is viewed as the likeliest winner1
. It is expected to point to that existing work, and is said to be open to splitting management of the platform across health service regions1
. The company declined to comment1
.Oracle Health, a finalist in the 2023 process, is seen as a potential bidder
1
. It would face questions over its contribution to British health-tech sovereignty, and did not reply to a request for comment1
.Palantir may argue it counts as a British company because the staff working on the platform are based in the UK
1
. Andrea Egan, Unison's general secretary, calls the platform "Both technically and ethically bankrupt"1
. Egan goes further: "Ministers should invest in that expertise instead of surrendering sovereignty over our most sensitive data to a private American surveillance firm"1
.Ministers are drawing up a new definition of a 'UK supplier' for procurement, due before the tender formally begins, and it could settle which companies are even allowed to compete
1
.Related Stories
Summarized by
Navi
[2]
02 Oct 2026•Policy and Regulation

03 Jun 2026•Policy and Regulation

09 Jul 2026•Policy and Regulation
